Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 260-300-4 | CAS number: 56634-95-8
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vivo
Administrative data
- Endpoint:
- in vivo mammalian somatic cell study: cytogenicity / erythrocyte micronucleus
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 27 Jun - 26 Jul 1991
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- guideline study with acceptable restrictions
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 991
- Report date:
- 1991
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 474 (Mammalian Erythrocyte Micronucleus Test)
- Version / remarks:
- adopted 1983
- Deviations:
- no
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 474 (Mammalian Erythrocyte Micronucleus Test)
- Version / remarks:
- adopted 2016
- Deviations:
- yes
- Remarks:
- No justification for route, duration and choice of vehicle provided, historical control data given without standard deviations, highest dose did not produce toxicity in bone marrow, only 1000 instead of 4000 immature erythrocytes per animal scored
- GLP compliance:
- yes
- Type of assay:
- mammalian erythrocyte micronucleus test
Test material
- Reference substance name:
- 3,5-dibromo-4-hydroxybenzonitrile
- EC Number:
- 216-882-7
- EC Name:
- 3,5-dibromo-4-hydroxybenzonitrile
- Cas Number:
- 1689-84-5
- Molecular formula:
- C7H3Br2NO
- IUPAC Name:
- 3,5-dibromo-4-hydroxybenzonitrile
Constituent 1
Test animals
- Species:
- mouse
- Strain:
- CD-1
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: supplied by Charles River Limited, Kent, UK
- Age at study initiation: 7 - 8 weeks
- Weight at study initiation: 25 - 36 g males and 21 - 29 g females
- Assigned to test groups randomly: yes, computer-generated randomization was used for the micronucleus study
- Fasting period before study: none
- Housing: individually in polypropylene and stainless steel cages measuring 48 cm x 15 cm x 13 cm
- Diet: SDS Rat and Mouse Maintenance Diet No. 1 (Special Diet Services Limited, Essex, UK), ad libitum
- Water: ad libitum
- Acclimation period: at least 11 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 18 - 21
- Humidity (%): 37 - 65
- Photoperiod (hrs dark / hrs light): 12/12
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- - Vehicle/solvent used: Corn oil
- Details on exposure:
- PREPARATION OF DOSING SOLUTIONS:
Immediately prior to dosing, the test compound was suspended in corn oil. The dose volume used for the control and test compound treated animals was a constant 10 mL/kg bw. - Duration of treatment / exposure:
- Single treatment
- Frequency of treatment:
- Once
- Post exposure period:
- Test substance:
- 35 mg/kg bw: 24 h
- 70 mg/kg bw: 24 h
- 105 mg/kg bw: 24, 48, 72 h
Control animals: 24, 48, 72 h
Positive control: 24, 48, 72 h
Doses / concentrationsopen allclose all
- Dose / conc.:
- 35 mg/kg bw (total dose)
- Dose / conc.:
- 70 mg/kg bw (total dose)
- Dose / conc.:
- 105 mg/kg bw (total dose)
- No. of animals per sex per dose:
- 5
- Control animals:
- yes, concurrent vehicle
- Positive control(s):
- Cyclophosphamide
- Route of administration: gavage
- Doses / concentrations: 80 mg/kg bw
Cyclophosphamide was prepared fresh as an 8 mg/mL solution in distilled water and administered to the positive control animals in standard dose volumes of 10 mL/kg bw.
Examinations
- Tissues and cell types examined:
- Bone marrow
- Details of tissue and slide preparation:
- CRITERIA FOR DOSE SELECTION:
The dose selection was based on a dose range-finding study. 5 groups of 2 male and female CD-1 mice were dosed orally with 100, 250, 400, 550 and 700 mg/kg bw of the test substance. These dose level were chosen based on acute oral LD50 information in rats. The mice were observed for clinical signs or mortality at frequent intervals (1 min, 0.5 h, 1 h, 2 h and 4 h) post dosing, then daily until the end of the observation period. Surviving animals were killed 14 days after dosing, by C02 asphyxiation. Gross pathology was performed on all animals, following compound-induced death or scheduled kill. Based on the results, animals in the main toxicity test were dosed with 50, 125, 200 and 275 mg/kg bw of the test substance. In the main toxicity test, groups of 5 male and 5 female mice were orally treated on a single occasion. Following a similar test procedure as in the range-finding test, animals were observed at the time of dosing and at 1 min, 0.5 h, 1 h, 2 h and 4 h after treatment, then daily until the end of the observation period for clinical signs or mortality. Surviving animals were killed 14 days after dosing by C02 asphyxiation. Based on the results of this study, the doses for the micronucleus test were selected.
TREATMENT AND SAMPLING TIMES:
In the micronucleus test, 5 groups of male and female CD-1 mice were dosed once at 0 h with test or control agents, then marrow samples taken at time intervals of 24 h. In addition, bone marrow was also prepared after 48 and 72 h from animals treated with the positive and vehicle control and 105 mg/kg bw of the test substance. Mice were killed by cervical dislocation.
DETAILS OF SLIDE PREPARATION:
The femora were dissected out and freed of adherent tissue. A small hole was made in the neck of one femur and the marrow flushed, using a 1 mL syringe fitted with a gauge 25 needle, into a heparinized centrifuge tube containing 3 mL of a 1:1 mixture of fetal calf serum and 0.8% trisodium citrate in Sorenson's buffer, pH 6.8. This mildly hypotonic treatment served to make the micronuclei clearly visible and to distinguish them from surrounding artefacts. The contents of the tubes were briefly agitated on a vortex mixer to allow separation of the cells. The tubes were centrifuged to pellet the cells. All but a few drops of supernatant fluid was discarded. The cells were then resuspended on a vortex mixer in this residual amount of supernatant liquid. A drop of the suspension was placed at one end of the slide and a smear made by drawing the top of a Pasteur pipette horizontally along the slide. Two slides were prepared from each tube and animal. The smear was left to air dry, fixed in methanol and stained with 1% May-Grunwald in methanol and Sorenson's buffer and counterstained in 15% Giemsa (Gurr) in Sorenson's buffer. The stained smears were rinsed in 3 changes of distilled water and air dried. Finally, the smears were cleared in Histo-clear and permanent slide preparations obtained by sealing glass coverslips onto the microscopic slides using DPX mountant.
METHOD OF ANALYSIS:
Micronuclei were analyzed with a light microscope. 1000 polychromatic erythrocytes (PCE) were counted per animal. The number of micronucleated normochromatic erythrocytes (NCE) was also recorded. The PCE/NCE ratio was determined for each animal by counting the number of immature (PCE) per mature (NCE) erythrocytes in a minimum total of 500 cells (PCE + NCE). - Evaluation criteria:
- Evaluation of the results were based on Salamone et al. 1980 and Tamura et al. 1990 and laboratory historical control data. Based on a mean frequency of micronucleated PCE of 0.128% per mouse (Salamone et al. 1980a) and 0.122% in CD-1 mice for both sexes combined (Tamura et al. 1990), a positive response was suspected if the total numbers of micronuclei within any one sample group of a given number of mice exceeded the criteria adopted from Salamone et al. (1980) or the corresponding value of the historical control data (shown in attachment 1).
A micronucleus within a polychromatic or normochromatic erythrocyte was defined as a distinct Giemsa-positive body of evident chromosomal origin and enclosed by the cytoplasm of the harboring cell. - Statistics:
- Statistical analysis was not performed.
Results and discussion
Test results
- Key result
- Sex:
- male/female
- Genotoxicity:
- negative
- Toxicity:
- yes
- Remarks:
- One male treated with 105 mg/kg bw died, but no clinical signs or changes in the PCE/NCE ratios were observed.
- Vehicle controls validity:
- valid
- Negative controls validity:
- not examined
- Positive controls validity:
- valid
- Additional information on results:
- RESULTS OF RANGE-FINDING STUDY
The dose selection was based on a dose range-finding study. 5 groups of 2 male and female CD-1 mice were dosed orally with 100, 250, 400, 550 and 700 mg/kg bw of the test substance. Treatment-related deaths were observed at all doses examined. No abnormal clinical signs were observed prior to death. Gross pathology revealed no compound related findings except autolysis in one female and bright red lungs in two females. Based on the results, animals in the main toxicity test were dosed with 50, 125, 200 and 275 mg/kg bw of the test substance.
RESULTS OF THE MAIN TOXICITY TEST
In the main toxicity test, groups of 5 male and 5 female mice were orally treated on a single occasion. No deaths occurred at 50 mg/kg bw, whereas deaths were observed in the higher dose groups as follows:
125 mg/kg bw: 1/5 males and 1/5 females
200 mg/kg bw: 4/5 males and 3/5 females
275 mg/kg bw: 5/5 males and 3/5 females
These deaths were preceded by dose-related clinical signs comprising reduced activity, piloerection, subdued behavior and hunched appearance (please also refer to the attachment 2). However, no changes were observed at the post mortem examination (14 days after treatment). Based on these results, the LD50 values were calculated for males (157 mg/kg bw) and for females (205 mg/kg bw). Therefore, the highest dose used in the micronucleus test was 105 mg/kg bw. For details, please refer to the attachment 2.
RESULTS OF THE MICRONUCLEUS TEST
- Clinical signs: No adverse reactions were observed following treatment.
- Mortality: One male died following exposure to 105 mg/kg bw of the test substance.
- Body weight: There was no evidence of body weight loss in the treated mice compared to the control animals.
- Induction of micronuclei: No differences were observed between control and treatment groups.
- Ratio of PCE/NCE: No differences were observed between control and treatment groups.
- Positive control: Substantial induction of bone marrow micronuclei at all 3 sampling times were observed in animals treated with 80 mg/kg bw cyclophosphamide. The positive control also caused a decline in PCE/NCE ratios and therefore affected normal cellular proliferation.
- Vehicle control: The numbers of micronucleated bone marrow polychromatic erythrocytes (MN-PCE) in the control mice were within the in-house historical control range for negative control exposed mice at all experimental points.
For details, please refer to the attachment 3.
Applicant's summary and conclusion
- Conclusions:
- The study was performed according to OECD guideline 474 (1983) and compliant with GLP. Despite a number of deviations in regard to the current version of the OECD guideline 474 (2016), the study is considered acceptable. Under the conditions of this study, the test substance was found to be devoid of micronucleus inducing potential when tested to lethal doses in male and female CD-1 mice using a single oral exposure and multiple sampling times protocol.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.